CYTK - Cytokinetics says potential acquirer walked away
2024-06-05 10:28:20 ET
More on Cytokinetics
- Cytokinetics Decides To Go It Alone
-
Cytokinetics CEO Blum says positioned to market heart drug aficamten by itself
-
Cytokinetics drops after pricing public offering, debt deal; brokerages cut PT
-
Cytokinetics to get up to $575M in funding from Royalty Pharma
- Cytokinetics, Incorporated (CYTK) Q1 2024 Earnings Call Transcript